•01/2011 - present – Associate Professor - Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah, UAE.
•09/2011 - 01/2020 – Assistant Professor - Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah, UAE.
•02/2012 - 08/2019 - Associate Professor - Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
•04/2009 - 10/2009 - Visiting Assistant Professor - Department of Bioengineering and Department of Pharmaceutical Sciences, University of Utah, Salt Lake City, Utah, USA.
•01/2007 - 08/2011 - Consultant and Trainer - Archer Business Consultants, Cairo, Egypt.
•01/2006 - 08/2011 - Assistant Professor - Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
•01/2006 - 01/2007 - Visiting Professor – Department of Pharmaceutics, Misr International University, Cairo, Egypt.
•11/2004 - 12/2005 - Postdoctoral Fellow - Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD and Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Baltimore, MD, USA.
•12/1997- 08/1999 - Teaching Assistant - Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Egypt.
1.M. Haider, Z. Megeed and H. Ghandehari, Genetically engineered polymers: status and prospects for controlled release, Journal of Controlled Release, 95 (1), p1-26, 2004.
2.M. Haider, V. Leung, F. Ferrari, J. Crissman, J. Cappello, and H. Ghandehari, Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization, Molecular Pharmaceutics, 2 (2), p139-150, 2005.
3.M. Haider, A. Hatefi, H. Ghandehari, Recombinant polymers for cancer gene therapy: a minireview, Journal of Controlled Release, 109(1-3), p108-119, 2005.
4.M. Haider, J. Cappello, H. Ghandehari and K.W. Leong, In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels, Pharmaceutical Research 25(3), p692-9, 2008.
5.D. Hwang, V. Moolchandani, R. Dandu, M. Haider, J. Cappello and H. Ghandehari, Influence of polymer structure and biodegradation on DNA release from structurally related silk-elastinlike hydrogels, International Journal of Pharmaceutics, 368(1-2), p215-9, 2009.
6.K. Greish, A. Ray, H. Bauer, N. Larson, A. Malugina, D. Pike, M. Haider and H. Ghandehari, Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy, Journal of Controlled Release, 151 (3), p263-270, 2011.
7.M. Mohamed, M. Haider, M. A. Ali, Buccal Mucoadhesive Films Containing Antihypertensive Drug: In vitro/in vivo Evaluation, Journal of Chemical and Pharmaceutical Research, 3(6): p665-686, 2011
8.G. Abdelbary, M. Haider, In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate, Pharmaceutical Development and Technology, 18(5): p1159-68, 2013.
9.W.M. Talaat, M. Haider, S. A. Kawas, N.G. Kandil and D.R. Harding. Chitosan-based thermosensitive hydrogel for controlled drug delivery to the temporomandibular joint. Journal Craniofacial Surgery, 27(3): p735-40, 2016.
10.H.O. Ammar, M. Haider, M. Ibrahim, and N.M. El Hoffy. In-vitro and In-vivo Investigation for Optimization of Niosomal Ability for Sustainment and Bioavailability Enhancement of Diltiazem after Nasal Administration. Drug Delivery, 24 (1): p 414-421, 2017.
11.I.S. Ahmed, R. El Hosary, M.A. Hassan, M. Haider, M.M. Abd-Rabo. Efficacy and Safety Profiles of Oral Atorvastatin-Loaded Nanoparticles: Effect of Size Modulation on Biodistribution, Molecular Pharmaceutics, 15(1): p 247-255, 2018.
12.M. Haider, M. A. Hassan, I. S. Ahmed, R. Shamma. Thermogelling Platform for Baicalin Delivery for Versatile Biomedical Applications, Molecular Pharmaceutics, 15(8): p 3478−3488, 2018.
13.M. Haider, S.M. Abdin, L. Kamal, G. Orive, Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics: 12(3): p 288, 2020.
14.R. Hamdy, B. Fayed, A.M. Hamoda, M. Rawas-Qalaji, M. Haider, S.S.M. Soliman. Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation, Molecules, 25(6): p 1463, 2020.
15.Z. Hussain, H. E. Thu, M. Haider, S. Khan, M. Sohail, F. Hussain, F. M. Khan, M. A. Farooq, A. N. Shuid, A review of imperative concerns against clinical translation of nanomaterials: Unwanted biological interactions of nanomaterials cause serious nanotoxicity, Journal of Drug Delivery Science and Technology, 59: p 101867, 2020
16.M. Haider, A. Elsherbeny , J. Jagal , A. Hubatová-Vacková, I. S. Ahmed, Optimization and evaluation of poly(lactide-co-glycolide) nanoparticles for enhanced cellular uptake and efficacy of paclitaxel in the treatment of head and neck cancer, Pharmaceutics 12: p 828, 2020.
17.R. Hamdy, B. Fayed, A.M Hamoda, M. Rawas-Qalaji, M. Haider, S.S.M. Soliman, Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation, Molecules 25: p 1463, 2020.
18.W. Talaat, A.C.S. Aryal, S. Al Kawas, A.B.R. Samsudin, N.G. Kandile, D.R.K. Harding, M.M. Ghoneim, W. Zeiada, J. Jagal, A. Aboelnaga, M. Haider. Nanoscale Thermosensitive Hydrogel Scaffolds Promote the Chondrogenic Differentiation of Dental Pulp Stem and Progenitor Cells: A Minimally Invasive Approach for Cartilage Regeneration, International Journal of Nanomedicine 15: p7775-7789, 2020.
19.M. Haider, I., Elsayed, I.S. Ahmed, A.R. Fares. In situ-forming microparticles for controlled release of rivastigmine: In vitro optimization and in vivo evaluation, Pharmaceuticals, 14: p 1–21, 66, 2021.
20.F. Bahman, V. Pittalà, M. Haider, K. Greish. Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer. Journal of Personalized Medicine, 11(6): p559, 2021
21.M. Haider, A. Elsherbeny, V. Pittalà, A.N. Fallica, M.A. Alghamdi, K. Greish The Potential Role of Sildenafil in Cancer Management through EPR Augmentation. Journal of Personalized Medicine, 11(6): p585, 2021.